Lymphatic filariasis, caused by Wuchereria bancrofti and Brugia malayi, has been targeted by the World Health Organization for elimination as a public health problem by the year 2020. 1 Therefore, control programs have been or will be launched world-wide with an emphasis on communitywide treatment with diethylcarbamazine (DEC) and ivermectin or albendazole. 2 To monitor the success of such intervention programs, sensitive and cost effective diagnostic tools are required. It is estimated that 115 million people are infected with W. bancrofti and about 13 million with B. malayi. 3 In Asia, 1 of 5 filarial infections is due to B. malayi and in some countries this parasite is responsible for the majority of infections. 4, 5 Various sensitive polymerase chain reaction (PCR) assays have been established to detect W. bancrofti or B. malayi DNA in the human host or the mosquito vector. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Inhibition of a PCR, which may occur in both samples obtained from the mosquito vector and samples from the human host, is a common problem during DNA amplification and makes the standardization of PCR tests difficult. 16 Therefore, DNA constructs were used as internal standards (controls) in the PCR to avoid false-negative results in a diagnostic PCR. 17 For the detection of W. bancrofti, such internal control was developed and used in a PCR-ELISA-based method. 18 For traditional reasons, the assay was called a quantitative, competitive PCR-ELISA (QC-PCR-ELISA) method, although the method was rather semiquantitative than quantitative. However, the major application for the W. bancrofti PCR will be the detection of parasite DNA in the vector, since a simple, sensitive, and specific card test for the detection of circulating W. bancrofti antigen in human blood samples is now commercially available. 19 In contrast, for B. malayi there is no antigen test and the PCR is one of the most promising molecular approaches to detect the infection in both humans as well as in the vector.
In the present study we developed a PCR-ELISA method based on the Hha I repeat of B. malayi, 20 which involves the coamplification of an internal control. This method was evaluated on blood samples from persons living in an area endemic for nocturnally periodic B. malayi in central Sulawesi, Indonesia. To determine the sensitivity of the PCR-ELISA, we compared the results of the assay on blood samples collected during the night with those from samples collected during the day. We were able to demonstrate that the described method can be used to detect parasite DNA in day blood samples, which contained no microfilariae.
MATERIALS AND METHODS
Blood samples and DNA preparation. Blood samples were collected in July 1998 in the villages of Rogo and Mahoni of the Palu area in central Sulawesi, which is known to be endemic for nocturnally periodic B. malayi. 21 The principal vector species in this area is Anopheles barbirostris. In these villages, blood was collected from all inhabitants who consented to participate in the study. The collection of samples was approved by the Indonesian Ministry of Health. Following blood collection, treatment with DEC was offered. To obtain an overview regarding the prevalence of B. malayi, capillary night blood from 329 individuals in Rogo and from 326 individuals in Mahoni was examined in the field for microfilariae by a thick blood smear. The overall prevalence of infection in the examined children and adults was 8.5% (Rogo) and 6.1% (Mahoni). To study the detection of B. malayi DNA by the novel PCR-ELISA method, 10 ml of venous blood was collected into EDTA-coated vacutainers (Becton Dickinson, Inc., Heidelberg, Germany) from 113 randomly selected adults Ͼ14 years of age both during the daytime (between 10:00 AM and 1:00 PM) and during the night (between 8:00 PM and 11:00 PM). Only night blood samples were available from 25 adults. Individuals who participated in the study were registered, examined for clinical signs of filariasis, and interviewed for previous signs of the disease. During the stay in the field, the samples were kept refrigerated for up to one week and subsequently transported to a central laboratory at the Department of Parasitology at the University of Indonesia in Jakarta. All samples were examined for the presence of microfilariae by filtration of 1 ml blood through a membrane (5 m pore size; Nucleopore, Pleasanton, CA), followed by microscopic examination of the Giemsa-stained filter.
Microfilariae of B. malayi were obtained from a zoophilic strain that was reared in jirds for generations at the Department of Parasitology in Jakarta. Microfilariae from B. pahangi were obtained from TRS Laboratories (Athens, GA). As negative controls, 10 blood samples from Ugandan patients living in an area non-endemic for B. malayi, but endemic for the filarial parasites Onchocerca volvulus and Mansonella perstans, were used. To investigate the sensitivity of the PCR-ELISA, B. malayi microfilariae were examined under a stereomicroscope and individually transferred to 200 l of human blood (containing 1 mM EDTA) collected from noninfected North Americans.
Lysates of 200 l of blood from all samples prepared as previously described in detail 15 were used as PCR templates. Two microliters of the lysate were used in the PCR. If a high level of PCR inhibition was detected, the blood lysate was diluted 1:5 in sterile water and the PCR was repeated.
Polymerase chain reaction. The PCR conditions were the same as described previously, 12 but Taq Gold polymerase (PE Applied Biosystems, Foster City, CA, USA) was used with an initial activation step of 10 min at 95ЊC before starting DNA amplification. When 0.2-ml ultra-thin PCR tubes and a GeneAmp PCR System 9700 thermocycler (PE Applied Biosytems) were used, the periods of denaturation, annealing, and extension was decreased to 30 sec each. By using this thermocyler, the duration of the PCR was reduced to less than 2 hr and the amount of Taq polymerase could be reduced to 1.5 units per 50-l reaction. A 5Ј biotinylated Hha I-reverse primer was used to obtain a biotinylated PCR product, which can easily be bound to a streptavidin-coated microtiter plate. For each sample, 10 pg of the internal control was added to the PCR master mixture. The internal control is available free of charge from the authors. The internal control was constructed using an inverse PCR on the Hha I repeat with primers that changed the hybridization target sequence. The product of the inverse PCR was cloned in Escherichia coli and one clone was selected that had in addition to the expected nucleotide exchange in the hybridization region a small deletion of 12 basepairs. Eight microliters of each PCR product were run on a 1.5% agarose gel and visualized by staining with ethidium bromide.
The PCR-ELISA. The PCR-ELISA was performed as described previously for the detection of W. bancrofti, 18, 22 with a few B. malayi-specific modifications. For each sample, two of the wells were hybridized with the wild type Hha I-specific DNA probe (Bm-Hha) and two with the internal control-specific DNA probe (Bm-con). The oligonucleotide probes Bm-Hha (5Ј-ACGTGAATTGTACCAGTGCTGGTCG-3Ј) and Bm-con (5Ј-TTACGTCGCCCTTCG CTAGTCTCT-3Ј) were fluorescein-labeled at both the 5Ј and 3Ј ends during synthesis (Oligo Etc./Oligotherapeutics, Wilsonville, OR). Each probe was diluted to 50 pg/l in hybridization buffer and later detected using an anti-fluorescein-alkaline phosphatase-conjugated antibody (Boehringer Mannheim, Mannheim, Germany). Alkaline phosphatase substrate was added according to the instructions of the manufacturer (AP substrate tablets 104; Sigma, St. Louis, MO). The ELISA reading was performed at 405 nm following incubation for 1 hr at 37ЊC using a Vmax microplate reader (Molecular Devices, Sunnyvale, CA).
Data analysis. Data analysis was performed using the computer program Epi-Info version 6.02 (Centers for Disease Control and Prevention, Atlanta, GA) as described previously. 18 We found in a few cases too much PCR inhibition for accurate detection of positive samples. Therefore, if the optical density reading of the Bm-Hha wild-type probe (OD Bm-Hha ) or the Bm-con probe (OD Bm-con ) was Ͻ1, the assay was repeated as mentioned above. A positive OD Bm-Hha reading for a blood sample was defined as the OD Bm-Hha of the negative controls plus 5 times the standard deviation of the negative controls. The cut-off value varied between 0.11 and 0.253. For about 80% of the field-collected blood samples, positive OD Bm-Hha readings were Ͼ0.253. Negative controls contained PCR products from 10 pg of the internal control plasmid DNA and DNA extracts of blood samples from 10 uninfected persons from Uganda or from 3 persons from North America. Because 10 pg of the internal control plasmid were used as the competitor DNA in all samples, an index for the amount of B. malayi DNA present in positive samples was calculated as 10 times the relation of the OD BmHha of the sample to the OD Bm-con of the sample.
RESULTS

Development of the novel PCR-ELISA.
The amplification of the internal control was very efficient and as little as 1 fg of DNA was sufficient as PCR template in a 50-l reaction. However, the wild-type Hha I sequence is highly repeated and comprises about 13% of the entire genome of B. malayi. Therefore, in most samples containing moderate or high numbers of microfilariae the amount of wild-type target sequence was in such an excess that almost no internal-control PCR product was obtained that could be detected by the PCR-ELISA. To more accurately quantify the wildtype PCR product, the amount of internal control was increased to 10 pg per reaction. This was sufficient template to obtain detectable internal control PCR products even in the presence of an abundance of wild-type Hha I repeat, while, on the other hand, this amount of competitor DNA allowed the detection of low microfilaria densities or circulating DNA in microfilariae-negative samples.
The internal control was 12 basepairs shorter than the B. malayi wild-type Hha I repeat. This size difference was visible on a 1.5% agarose gel. In addition, since the wild-type Hha I repeat is organized as a tandem repeat, in some samples not only was the monomer amplified but also dimers and trimers of the wild-type repeat were amplified ( Figure  1 ). However, to quantify the amount of wild-type PCR product and of internal control PCR product and to increase the sensitivity, an ELISA detection was necessary.
Sensitvity of the PCR-ELISA. In a series of experiments, * Differences between the groups were significant (P ϭ 0.000001 by chi-square test). † The theoretical mean was 0.025 Ϯ 0.017, but in these experiments the cut-off value was calculated as 0.11. distinct numbers of B. malayi microfilariae were added to human blood samples and following lysis the PCR-ELISA was performed. The method was sensitive enough to detect a single microfilaria in 200 l of human blood (Table 1 ). All 31 samples containing microfilariae were positive and the 6 samples without microfilariae were negative in the assay. The microfilariae used in this experiment belonged to a zoophilic strain of the parasite that was reared in jirds. When microfilariae of the closely related filarial parasite B. pahangi were added to blood samples, the PCR-ELISA gave negative results. The results showed that a single B. malayi microfilaria contained sufficient DNA to be reliably detected in 200 l of human blood that was free of any circulating B. malayi DNA.
To determine the sensitivity of the assay to detect DNA of anthropophilic, nocturnally periodic B. malayi in naturally infected individuals, 138 blood samples were collected in central Sulawesi during the night and examined by the described PCR-ELISA method. Microfilariae were detected in 44 (31.9%) blood samples by filtration of 1 ml of night blood. Forty-one (29.7%) persons were also positive by the examination of a thick smear of capillary blood. The geometric mean microfilaria density in microfilaria carriers was 194 microfilariae/ml, ranging from 1 to 3,242 microfilariae/ ml blood. All samples from microfilaria carriers were positive by the PCR-ELISA, suggesting a sensitivity of 100%. In addition, 14 samples from amicrofilaremic were also found to be PCR-ELISA positive. The filtration of an additional ml blood of 7 of these 14 samples showed that 6 samples were again microfilaria negative, but 1 sample contained 3 microfilariae. Fifty-eight (42%) samples were found to be positive by the PCR-ELISA. All negative controls from African patients were negative in the assay. These results demonstrate that the described PCR-ELISA method has a higher sensitivity compared with the blood filtration.
The PCR-ELISA for diagnosis of clinical filariasis. Clinical signs associated with brugian filariasis were observed in only a few examined individuals from central Sulawesi. Three patients had elephantiasis on their legs. They were all microfilaria and PCR-ELISA negative. Two of them had received DEC treatment before 1991. Forty-three persons claimed a history of one or more acute filariasis attacks during the last year. Of these persons, 26 (60.5%) were microfilaria carriers, 28 (65.1%) were PCR-ELISA positive, and 6 (14%) reported previous malaria attacks. In contrast, among 88 persons without acute filariasis attacks 12 (13.6%) were microfilaria carriers, 25 (28.4%) were positive in the PCR-ELISA, and 17 (19.3%) had a history of malaria.
Detection of DNA of nocturnally periodic B. malayi in day blood. The collection of blood samples during the night involves serious logistical and social problems. Therefore, we examined the sensitivity of the novel PCR-ELISA method on 113 blood samples collected during daytime and compared their results with those from the corresponding night blood samples of the same individuals. Whereas 37 (32.7%) of these persons had microfilariae in their night blood as determined by blood filtration, all blood samples were microfilariae negative during the day. This finding supports the strong nocturnal periodicity of this strain of B. malayi. How- ever, B. malayi DNA was detected by PCR-ELISA in 34 (30.1%) of these day blood samples ( Table 2 ). The 6 PCR-ELISA-negative day blood samples of infected individuals were from persons with low microfilaria densities in their night blood: 2 of them had only 1 microfilaria/ml, and the others had 10, 59, 66, and 126 microfilariae/ml, respectively. Control samples from areas proven to be non-endemic for B. malayi were all negative by the PCR-ELISA. As summarized in Table 3 , the PCR-ELISA performed on night blood samples has a higher sensitivity than performed on day blood samples. The results above demonstrate the ability of the assay identify villages endemic for nocturnally periodic B. malayi examination of day blood samples.
Quantitation of the Hha I PCR product. When increasing numbers of microfilariae were added to 200 l of blood, an increasing relative amount of Hha I wild-type PCR product was detected by the PCR-ELISA (Table 1 ). This positive correlation was statistically significant (r ϭ 0.84, degrees of freedom [df] ϭ 30). A similar, but statistically nonsignificant correlation was observed for the PCR products of the 58 PCR-ELISA positive field collected night blood samples from Sulawesi. The comparison of the relative amount of wild-type Hha I PCR product obtained from PCR-ELISA positive night blood and day blood samples revealed a statistically significant difference, with an average relative amount of 9,106 units in night blood samples and an average relative amount of 1,061 units in day blood samples (P ϭ 0.0006, by Mann-Whitney U test). Although no significant correlation between the microfilaria density and the number of acute filariasis attacks could be shown for PCR-ELISApositive samples, a weak correlation was found between the relative amount of Hha I PCR product and the number of filariasis attacks (r ϭ 0.28, df ϭ 51). These results showed that the relative amount of Hha I PCR product may be both an indicator for the microfilarial load and for the occurrence of acute filariasis attacks in an endemic community.
DISCUSSION
The present study demonstrates that the described PCR-ELISA is an excellent method for detecting B. malayi DNA in blood samples. Using this method, it is possible to detect both zoophilic B. malayi strains that were reared in jirds as well as the anthropophilic, A. barbirostris-transmitted, nocturnally periodic strain from central Sulawesi. So far no sequence consistent differences of the Hha I repeat in different strains of B. malayi have been found and it was reported that the Hha I repeat of B. malayi is species specific and distinct from that of the closely related species B. pahangi. 20 Since the Hha I sequence is highly repeated and comprises about 13% of the whole B. malayi genome, this sequence appears to be preordained as PCR target for the development of specific and sensitive detection assays for this parasite.
The PCR-ELISA is sensitive and reliable enough to detect as little as one B. malayi microfilaria added to 200 l of blood. Therefore, this assay has at least the same or even a higher sensitivity than conventional PCR assays for the detection of filarial parasites. 7, [9] [10] [11] [12] It has been reported that a conventional PCR-ELISA without any internal control is a very sensitive tool for the detection of PCR products of the B. malayi Hha I repeat. 13 Our results confirmed this finding using a different labeling hapten and a different antibodyconjugate for the ELISA detection. In addition, we were able to show that an internal control can be used to avoid falsepositive results and the ELISA can be used to quantify PCR products to provide semiquantitative data. When evaluated on field-collected blood samples, the results of the present study suggest that the B. malayi PCR-ELISA is more sensitive than the corresponding PCR-ELISA method for the detection of W. bancrofti. 18 This may again be due to the fact that the Hha I PCR target sequence is highly repeated in a tandem array in contrast to the W. bancrofti target sequence, which has only about 300 dispersed copies per haploid genome. 11 The high abundance of the Hha I repeat in Brugia parasites may facilitate the sensitive detection of this molecule at physiologic levels without PCR. Although signal amplification techniques such as ultra-sensitive branched DNA assays have some advantage compared with the PCR, they have been developed so far only for a limited number of viral and bacterial agents. 23 It remains an objective for further research whether signal amplification methods can be developed that are as sensitive and easy to perform as the described B. malayi PCR-ELISA.
Diagnostic procedures for brugian filariasis, which could be useful as a screening tool for large-scale intervention programs, should involve convenient sample collection procedures. The diagnosis of nocturnally periodic filariasis in day blood samples would facilitate the sample collection enormously. Therefore, the World Health Organization Expert Committee on Filariasis recommended the development and validation of diagnostic assays that can replace night blood examination for detection of microfilaremia. 24 Using the described PCR-ELISA on night blood samples as a reference method, the sensitivity of the PCR-ELISA method per-formed on 200 l of day blood revealed a similar sensitivity as the filtration of 1 ml of night blood. In agreement with these results, the detection of DNA of nocturnally periodic W. bancrofti by PCR in day blood samples has been recently reported. 10 In this study, a conventional PCR performed on DNA extracts from 500 l of day blood plasma was compared with a thick blood film prepared from 60 l of night blood. However, we were able to show that the novel PCR-ELISA method is capable of detecting free DNA of nocturnally periodic B. malayi in as little as 200 l of day blood while still achieving a sensitivity comparable with the filtration of 1 ml of night blood.
On the basis of the W. bancrofti PCR-ELISA test results, it could not be recommended to estimate the worm burden in infected individuals because of its high standard deviation. However, on a community level, an excellent agreement between microfilariae density and the PCR-ELISA result was observed. Therefore, this method is suitable for the evaluation of parasitic loads in the community-based diagnosis of filariasis. 18 Our results from the B. malayi PCR-ELISA support this finding, although the standard deviation is even higher and no significant correlation could be proven. This may be due to the fact that individuals who are capable of killing microfilariae efficiently and have, therefore, low microfilariae densities, may have huge amounts of Hha I PCR target DNA in their blood, because up to 130 fg of the Hha I repeat can be released by a single dead microfilaria. Therefore, further studies are required to elucidate the relationship between microfilaria density and the amount of parasite DNA in blood samples of infected individuals with different immunologic status. This is also of relevance in exploring the dynamics of B. malayi DNA clearance following chemotherapy. Furthermore, a more standardized procedure for DNA extraction is desirable.
For the monitoring of filariasis control programs, specific and very sensitive diagnostic assays are required. However, it appears difficult to define how sensitive a method has to be and what are the thresholds for prevalence in humans and for the vector infection rate to interrupt transmission. In China, the threshold prevalence for transmission of B. malayi by A. sinensis is estimated to be between 1.55% and 2.23% of the human population, providing no individual has a higher microfilaria density than 12 microfilariae/60 l of capillary night blood. 25 This low microfilaria density would correspond to 30 microfilariae/ml of venous night blood. 26 Depending on the mosquito biting rate, the threshold for the vector infection rate was in the Chinese study estimated to be between 0.23% and 0.024%. Our results from the blood screening experiments suggest that the described PCR-ELISA is a suitable method to detect such low prevalence even when performed on day blood. In addition, preliminary results indicate that the novel PCR-ELISA is also an excellent tool for mosquito pool screening to detect the low threshold vector infection rates (Supali T and others, unpublished data). Therefore, the PCR-ELISA method has the capacity for the monitoring of low endemicity areas and may help to avoid premature cessation of control programs and protect these areas from a resurgence of filariasis. Taken together, the described PCR-ELISA test for the DNA detection of B. malayi is a powerful new diagnostic tool that can be applied not only on blood samples collected during the night, but also on day blood samples. In addition, the test appears most suitable for the rapid detection of B. malayi in individual or pools of vector mosquitoes. This test may complement existing diagnostic tools involved in intervention programs, which aim to eliminate lymphatic filariasis as a public health problem in the near future.
